PI
ABBV icon

PEAK6 Investments’s AbbVie ABBV Stock Holding History

PEAK6 Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$19.2M Buy
97,100
+35,600
+58% +$6.64M 0.04% 352
2024
Q2 		$10.5M Buy
61,500
+8,900
+17% +$1.47M 0.03% 467
2024
Q1 		$9.58M Sell
52,600
-119,000
-69% -$20.5M 0.03% 539
2023
Q4 		$26.6M Sell
171,600
-2,700
-2% -$394K 0.1% 181
2023
Q3 		$26M Sell
174,300
-63,100
-27% -$9.26M 0.12% 127
2023
Q2 		$32M Buy
237,400
+41,600
+21% +$6.1M 0.15% 103
2023
Q1 		$31.2M Buy
195,800
+165,700
+550% +$25.3M 0.15% 117
2022
Q4 		$4.86M Sell
30,100
-83,200
-73% -$12.8M 0.03% 740
2022
Q3 		$15.2M Sell
113,300
-293,400
-72% -$42.1M 0.06% 292
2022
Q2 		$57.9M Buy
406,700
+74,300
+22% +$11.4M 0.11% 145
2022
Q1 		$53.9M Buy
332,400
+145,000
+77% +$21.1M 0.11% 156
2021
Q4 		$25.4M Buy
187,400
+21,400
+13% +$2.53M 0.05% 340
2021
Q3 		$17.9M Sell
166,000
-5,900
-3% -$674K 0.04% 432
2021
Q2 		$19.4M Buy
171,900
+9,200
+6% +$1.04M 0.05% 379
2021
Q1 		$17.6M Sell
162,700
-150,880
-48% -$16.1M 0.04% 395
2020
Q4 		$33.6M Sell
313,580
-245,700
-44% -$23.6M 0.07% 248
2020
Q3 		$49M Sell
559,280
-241,600
-30% -$22.7M 0.12% 150
2020
Q2 		$78.6M Buy
800,880
+220,080
+38% +$19.4M 0.27% 68
2020
Q1 		$44.3M Sell
580,800
-32,900
-5% -$2.8M 0.26% 64
2019
Q4 		$54.3M Buy
613,700
+215,000
+54% +$17.8M 0.28% 59
2019
Q3 		$29.8M Sell
398,700
-99,000
-20% -$6.79M 0.19% 91
2019
Q2 		$36.2M Buy
497,700
+422,600
+563% +$33.2M 0.24% 57
2019
Q1 		$6.05M Sell
75,100
-1,400
-2% -$115K 0.04% 600
2018
Q4 		$7.05M Sell
76,500
-115,000
-60% -$10.1M 0.04% 473
2018
Q3 		$18.1M Buy
+191,500
New +$18.2M 0.08% 249

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's ABBV Position: Q3 2024 in Review

PEAK6 Investments increased its AbbVie (ABBV) stake by 502% in Q3 2024, buying an estimated $2.22M and bringing the position to 14,248 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #1290.

PEAK6 Investments first reported a position in ABBV in Q3 2018 and has held it in 20 quarters since. The position peaked at $15.8M in Q2 2019. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • PEAK6 Investments held 14,248 shares of AbbVie worth $2.81M as of Q3 2024.
  • PEAK6 Investments bought 11,883 AbbVie shares in Q3 2024, an estimated $2.22M.
  • AbbVie made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1290 holding.
  • PEAK6 Investments first reported a position in AbbVie in Q3 2018 and has held it in 20 quarters since.
  • PEAK6 Investments's AbbVie position peaked at $15.8M in Q2 2019.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.